Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar jesseangels (< 20) Submitted: 1/13/2012 7:41:59 PM : Outperform Start Price: $39.20 LLY Score: +3.33

Undervalued. Target ~50$.

Report this Post Reply

Featured Broker Partners


Advertisement